loading

You are welcome to send your RFP, feasibility questionnaire or other request at info@mt.clinic

    PHASE 1 STUDIES

    Early phase research is on the rise in Russia due to the governmental support aimed at successful creation and production of innovative medicines, which need be tested in humans, and its export.

    Institute of Human Brain, working in Medical Technologies network, has needed infrastructure and equipment for phase I trials conduct in accordance with international standards.

    Medical Technologies is specializing in early stages of drug development. Our site performs the following studies:

    • From first-in-human to proof-of-concept studies
    • Single and multiple doses studies
    • Drug and food interaction studies
    • PK and PD studies
    • Bioequivalence studies

    The following services are provided within phase I research:

    • Study subject enrollment
    • Study subject screening
    • Study procedures conduct
    • Study subjects reimbursement

    Medical Technologies has access to different study subjects including

    • Healthy volunteers
    • Special populations
    • Patients

    Our team experience includes dozens of first-in-human trials. Medical Technologies has experience working with biological drugs.

    Medical Technologies is your reliable partner for phase I trials with healthy volunteers. The investigational site provides the following benefits:

    • A big database of volunteers who participated in a clinical trial at least once
    • Subject enrollment within several days (depending on the number of volunteers)
    • Quick subjects screening
    • Established procedures of blood sampling and team work
    • Standardized environment for clinical trials
    • Standardized meals for volunteers
    • Payments to volunteers (bank transfer)
    • Dedicated team of investigators and nurses
    • Data entry operators who complete CRFs in a short period of time
    • Capability of conducting complex procedures
    • Intensive Care Department

    Medical Technologies can work not only in studies in healthy volunteers but also early phase studies in patients with oncology and autoimmune diseases.

    PHASE 2-3 STUDIES

    Medical Technologies participates in multi-center clinical studies sponsored by leading Russian and foreign pharmaceutical companies and Contract Research Organizations.

    Our clients choose Medical Technologies for we have highly-qualified investigators, most of whom have experience in international multi-center clinical studies since 1990s, Medical Technologies’ ability to provide high-technology medical care.

    We perform clinical studies in the following therapeutic specialties:

    • Allergology
    • Gastroenterology
    • Hepatology
    • Gynecology
    • Cardiology
    • Oncology
    • Pulmonology
    • Rheumatology
    • Traumatology
    • Urology
    • Endocrinology and
    • Diabetology
    • Other

    The Medical Technologies team will be glad to participate in study feasibilities and complete study questionnaires.

    Medical Technologies works with a wide network of referring clinics and doctors. For example, Medical Technologies’ database of patients includes:

    • 12,000 patients – oncology
    • 4800 patients – diabetes mellitus type II
    • 3200 patients – rheumatology
    • 2500 patients – gynecology
    • 2000 patients – allergology
    • 2000 patients – urology
    • 1300 patients – pulmonology
    • 240 patients – type I diabetes mellitus
    • 50 patients – oncohematology

    Medical Technologies is a reliable partner for phase II-IV clinical trials because the site provides the following advantages:

    • Thorough feasibility
    • Quick start-up
    • Agreement process takes 2 weeks
    • Preliminary review of documents by LEC before study approval by LEC
    • Quick enrolment thanks to a good network of referring doctors and site and other subject enrollment initiatives
    • Thorough patients screening
    • Investigators’ focus on subject health and well-being
    • Patient retention programs
    • High quality standards
    • Dedicated team of data entry operators
    • Source documents templates
    • Quick completion of CRFs with good quality
    • Experience working with different types of CRFs
    • Experienced investigators

    Phase II-IV trials are performed by two departments:

    • Oncology department
    • Healthy volunteers and Somatic department

    The oncology department performs clinical trials in oncology.

    The somatic department performs clinical trials in main therapeutic areas, excluding oncology.

    The following clinical research sites work in phase II-III trials:

    • Medical Technologies
    • Strategic Medical Systems
    • Institute of Human Brain of the Russian Academy of Sciences
    Our Services
    Explore Our Main Service
    Studies
    Phase (1-3) studies

    Clinical trials in phases one to three test the safety and efficacy of a new drug or treatment.

    Studies
    BIOEQUIVALENCE STUDIES

    To ensure that a generic drug has the same therapeutic effect as the original drug.

    Research
    SCIENTIFIC RESEARCH

    It involves study of phenomena through observation, experimentation and data analysis.

    Ethics Committee
    LEC APPROVAL

    We acquires ethical approval from its Local Ethics Committee for human participant clinical research.

    home service
    CLINICAL TRIAL AT HOME Service

    Our clients choose us for we have highly-qualified doctors and  investigators with high experience.

    clinical study
    STUDY ASSESSMENT

    We offer clinical study assessment, including ethical, regulatory, medical, and feasibility reviews.